Affiliation:
1. Faculty of Medicine and Health Care, Al-Farabi Kazakh National University
2. Department of Oncosurgery, Almaty Regional Multidisciplinary Clinic
3. Department of Oncology and Mammology, Kazakh-Russian Medical University
4. Department of Oncosurgery, Kazakh Research Institute of Oncology and Radiology
5. Department of Oncosurgery, Almaty Oncology Center, Almaty, Republic of Kazakhstan
Abstract
Objective
The purpose of the study is to analyze the immediate outcomes and results of video-assisted thoracoscopic lobectomy and lung resection performed in the surgical department of the AOC between 2014 and 2018.
Methods
For the period from 2014 to 2018, 118 patients with peripheral lung cancer were operated on in the surgical department of the AOC. The following operations were performed: lobectomy in 92 cases (78%), of which: upper lobectomy, 44 (47.8%); average lobectomy, 13 (14.1%); lower lobectomy, 32 (35%); bilobectomy, 3 (3.3%). All patients underwent extensive lymphadenectomy on the side of the operation. In 22 patients, for various reasons, preservation of thoracotomy was performed.
Results
The absence of N0 lymph node damage was observed in 82 patients (70%), the first-order lymph node damage N1 in 13 (11%), N2 in 13 (11%), N3 in 5 (4%), and NX in 5 (4%). Histological examination revealed: squamous cell carcinoma − 35.1%, adenocarcinoma − 28.5%, undifferentiated carcinoma − 8.3%, NSCLC − 5.6%, NEO − 4.6%, sarcoma − 1.8%. At the same time, in 12.7% of patients, mts was detected − lung damage, and in 3.4%, malignant cells were not detected. Most patients were activated on the first day after surgery.
Conclusion
An analysis of the direct results of the study allows us to conclude that video-assisted thoracoscopic surgery is a highly effective, minimally invasive, safe method for treating peripheral lung cancer, which allows us to recommend it for wider use in oncological practice.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology